Literature DB >> 19371612

Genetic polymorphisms in AS3MT and arsenic metabolism in residents of the Red River Delta, Vietnam.

Tetsuro Agusa1, Hisato Iwata, Junko Fujihara, Takashi Kunito, Haruo Takeshita, Tu Binh Minh, Pham Thi Kim Trang, Pham Hung Viet, Shinsuke Tanabe.   

Abstract

To elucidate the role of genetic factors in arsenic (As) metabolism, we studied associations of single nucleotide polymorphisms (SNPs) in As (+3 oxidation state) methyltransferase (AS3MT) with the As concentrations in hair and urine, and urinary As profile in residents in the Red River Delta, Vietnam. Concentrations of total As in groundwater were 0.7-502 mug/l. Total As levels in groundwater drastically decreased by using sand filter, indicating that the filter could be effective to remove As from raw groundwater. Concentrations of inorganic As (IAs) in urine and total As in hair of males were higher than those of females. A significant positive correlation between monomethylarsonic acid (MMA)/IAs and age in females indicates that older females have higher methylation capacity from IAs to MMA. Body mass index negatively correlated with urinary As concentrations in males. Homozygote for SNPs 4602AA, 35991GG, and 37853GG, which showed strong linkage disequilibrium (LD), had higher percentage (%) of dimethylarsinic acid (DMA) in urine. SNPs 4740 and 12590 had strong LD and associated with urinary %DMA. Although SNPs 6144, 12390, 14215, and 35587 comprised LD cluster, homozygotes in SNPs 12390GG and 35587CC had lower DMA/MMA in urine, suggesting low methylation capacity from MMA to DMA in homo types for these SNPs. SNPs 5913 and 8973 correlated with %MMA and %DMA, respectively. Heterozygote for SNP 14458TC had higher MMA/IAs in urine than TT homozygote, indicating that the heterozygote may have stronger methylation ability of IAs. To our knowledge, this is the first study on the association of genetic factors with As metabolism in Vietnamese.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19371612     DOI: 10.1016/j.taap.2009.01.015

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  32 in total

1.  Arsenic exposure and toxicology: a historical perspective.

Authors:  Michael F Hughes; Barbara D Beck; Yu Chen; Ari S Lewis; David J Thomas
Journal:  Toxicol Sci       Date:  2011-07-12       Impact factor: 4.849

2.  Interactive Influence of N6AMT1 and As3MT Genetic Variations on Arsenic Metabolism in the Population of Inner Mongolia, China.

Authors:  Xushen Chen; Xiaojuan Guo; Ping He; Jing Nie; Xiaoyan Yan; Jinqiu Zhu; Luoping Zhang; Guangyun Mao; Hongmei Wu; Zhiyue Liu; Diana Aga; Peilin Xu; Martyn Smith; Xuefeng Ren
Journal:  Toxicol Sci       Date:  2016-09-16       Impact factor: 4.849

3.  Direct analysis and stability of methylated trivalent arsenic metabolites in cells and tissues.

Authors:  Jenna M Currier; Milan Svoboda; Tomáš Matoušek; Jiří Dědina; Miroslav Stýblo
Journal:  Metallomics       Date:  2011-10-21       Impact factor: 4.526

4.  Mendelian randomization of inorganic arsenic metabolism as a risk factor for hypertension- and diabetes-related traits among adults in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) cohort.

Authors:  Molly Scannell Bryan; Tamar Sofer; Yasmin Mossavar-Rahmani; Bharat Thyagarajan; Donglin Zeng; Martha L Daviglus; Maria Argos
Journal:  Int J Epidemiol       Date:  2019-06-01       Impact factor: 7.196

5.  Analysis of maternal polymorphisms in arsenic (+3 oxidation state)-methyltransferase AS3MT and fetal sex in relation to arsenic metabolism and infant birth outcomes: Implications for risk analysis.

Authors:  Zuzana Drobná; Elizabeth Martin; Kyung Su Kim; Lisa Smeester; Paige Bommarito; Marisela Rubio-Andrade; Gonzalo G García-Vargas; Miroslav Stýblo; Fei Zou; Rebecca C Fry
Journal:  Reprod Toxicol       Date:  2016-02-27       Impact factor: 3.143

Review 6.  Effects of arsenic toxicity beyond epigenetic modifications.

Authors:  Geir Bjørklund; Jan Aaseth; Salvatore Chirumbolo; Mauricio A Urbina; Riaz Uddin
Journal:  Environ Geochem Health       Date:  2017-05-08       Impact factor: 4.609

Review 7.  Arsenic Exposure and Immunotoxicity: a Review Including the Possible Influence of Age and Sex.

Authors:  Daniele Ferrario; Laura Gribaldo; Thomas Hartung
Journal:  Curr Environ Health Rep       Date:  2016-03

8.  Phase 1 study of arsenic trioxide, high-dose cytarabine, and idarubicin to down-regulate constitutive signal transducer and activator of transcription 3 activity in patients aged <60 years with acute myeloid leukemia.

Authors:  Meir Wetzler; Chris Andrews; Laurie A Ford; Sheila Tighe; Maurice Barcos; Sheila N J Sait; Annemarie W Block; Norma J Nowak; Maria R Baer; Eunice S Wang; Heinz Baumann
Journal:  Cancer       Date:  2011-03-31       Impact factor: 6.860

9.  Genetic Determinants of Reduced Arsenic Metabolism Efficiency in the 10q24.32 Region Are Associated With Reduced AS3MT Expression in Multiple Human Tissue Types.

Authors:  Meytal Chernoff; Lin Tong; Kathryn Demanelis; Donald Vander Griend; Habib Ahsan; Brandon L Pierce
Journal:  Toxicol Sci       Date:  2020-08-01       Impact factor: 4.849

10.  Environmental exposure to arsenic, AS3MT polymorphism and prevalence of diabetes in Mexico.

Authors:  Zuzana Drobná; Luz M Del Razo; Gonzalo G García-Vargas; Luz C Sánchez-Peña; Angel Barrera-Hernández; Miroslav Stýblo; Dana Loomis
Journal:  J Expo Sci Environ Epidemiol       Date:  2012-10-24       Impact factor: 5.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.